Expert Opin Drug Metab Toxicol [PDF]
Introduction:Tedizolid is indicated for the treatment of acute bacterial skin and skin structure infections (ABSSSI). Although tedizolid shares many similar properties with linezolid, another oxazolidinone used to treat ABSSSI, the two antibiotics have ...
core
Tedizolid-Cyclodextrin System as Delayed-Release Drug Delivery with Antibacterial Activity
Progressive increase in bacterial resistance has caused an urgent need to introduce new antibiotics, one of them being oxazolidinones with their representative tedizolid. Despite the broad spectrum of activity of the parent tedizolid, it is characterized
Judyta Cielecka-Piontek +7 more
core +1 more source
Oxidative stress is two‐sided in the treatment of acute myeloid leukemia
Abstract Introduction Oxidative stress caused by elevated ROS, as a novel therapeutic mechanism, has been implicated in various tumors including AML. AML cells are chronically under oxidative stress, yet overreliance on ROS production makes tumor cells increasingly vulnerable to further damage. Reducing the cytotoxic effect of ROS on normal cells while
Chenyang Fan +3 more
wiley +1 more source
Pharmacodynamic evidence for tedizolid use in Mycobacterium avium lung disease
OBJECTIVE: On guideline-based therapy for Mycobacterium avium complex (MAC) lung disease (LD), ∼50%–60% of patients suffer recalcitrant disease. Tedizolid is a promising agent based on the intracellular hollow fibre model of MAC-LD (HFS-MAC) using the ...
D. Deshpande, S. Srivastava, T. Gumbo
doaj +1 more source
Pulmonary nocardiosis treated with tedizolid.
-
José María Gutiérrez-Urbón +4 more
openaire +3 more sources
Potential of the Introduction of Tedizolid for the Treatment of Complicated Skin and Soft Tissue Infections in a Russian Multi-Field Hospital [PDF]
Increase in prevalence of methicillin-resistant Staphylococcus aureus (MRSA) strains among the pathogens of complicated skin and soft tissue infections (cSSTIs) in hospitalised patients demands introduction of new treatment options with improved efficacy
Belkova Yu.А. +5 more
doaj
Lingbo Wang,1,* Ying Zhang,2,* Shixing Liu,1 Na Huang,1 Weiliang Zeng,1 Wenya Xu,1 Tieli Zhou,1 Mo Shen1 1Department of Clinical Laboratory, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, People’s ...
Wang L +7 more
doaj
Comparative Efficacies of Tedizolid Phosphate, Vancomycin, and Daptomycin in a Rabbit Model of Methicillin-Resistant Staphylococcus aureus Endocarditis [PDF]
Tedizolid, the active component of the prodrug tedizolid phosphate, is a novel oxazolidinone that is approximately 4 times more active by weight than linezolid against Staphylococcus aureus in vitro.
Chan, Liana C +3 more
core +1 more source
Tedizolid: A comprehensive review of pharmacology, clinical applications and future directions in antimicrobial resistance [PDF]
Tedizolid phosphate, a second-generation xazolidinone, has emerged as a valuable tool in the treatment of Gram-positive bacterial infections, particularly those caused by multidrug-resistant organisms such as methicillin-resistant Staphylococcus aureus ...
Shambo Samajdar +7 more
doaj +1 more source
Acute bacterial skin and soft tissue infections: new drugs in ID armamentarium
Acute bacterial skin and soft tissue infections (SSTI) are among the most common reasons for hospitalization of adults in the USA today. Cellulitis or SSTI can cause significant morbidity and mortality.
Raghavendra Tirupathi +4 more
doaj +1 more source

